Detailed Information on Publication Record
2020
Thermostable FGF2 Polypeptide, Use Thereof
DVOŘÁK, Petr, Pavel KREJČÍ, Lukáš BÁLEK, Lívia EISELLEOVÁ, Žaneta KONEČNÁ et. al.Basic information
Original name
Thermostable FGF2 Polypeptide, Use Thereof
Authors
DVOŘÁK, Petr (203 Czech Republic, guarantor, belonging to the institution), Pavel KREJČÍ (203 Czech Republic, belonging to the institution), Lukáš BÁLEK (203 Czech Republic, belonging to the institution), Lívia EISELLEOVÁ (203 Czech Republic, belonging to the institution), Žaneta KONEČNÁ (203 Czech Republic, belonging to the institution), Pavel DVOŘÁK (203 Czech Republic, belonging to the institution), David BEDNÁŘ (203 Czech Republic, belonging to the institution), Jan BREZOVSKÝ (203 Czech Republic, belonging to the institution), Eva ŠEBESTOVÁ (203 Czech Republic, belonging to the institution), Radka CHALOUPKOVÁ (203 Czech Republic, belonging to the institution), Veronika ŠTĚPÁNKOVÁ (203 Czech Republic), Pavel VAŇÁČEK (203 Czech Republic), Zbyněk PROKOP (203 Czech Republic), Jiří DAMBORSKÝ (203 Czech Republic, belonging to the institution) and Michaela BOSÁKOVÁ (203 Czech Republic, belonging to the institution)
Edition
Number: EP3380508, Publisher: European Patent Office, Place of publication: Munich, Owner's name: Masarykova univerzita; Enantis s.r.o. 2020
Other information
Language
English
Type of outcome
Patent
Field of Study
10600 1.6 Biological sciences
Country of publisher
Germany
Confidentiality degree
není předmětem státního či obchodního tajemství
References:
RIV identification code
RIV/00216224:14310/20:00114963
Organization unit
Faculty of Science
Keywords in English
Fibroblast Growth Factor 2; FGF2
Tags
Změněno: 8/4/2021 18:16, Mgr. Marie Šípková, DiS.
Abstract
V originále
The present invention relates to engineered Fibroblast Growth Factor 2 (FGF2, bFGF) having improved thermal stability compared to the wild-type and the use thereof in the cell biology research, regenerative medicine and related medical applications or cosmetics. The present invention further relates to a culture medium comprising FGF2 suitable for culturing a human pluripotent stem cells involving both human embryonic stem cells and induced pluripotent stem cells.
Links
| LO1214, research and development project |
|